Clinical and preclinical validation of the serum free light chain assay: Identification of the critical difference for optimized clinical use

European Journal of Haematology

Volumn 89, Issue 6, 2012, Pages 458-468

  Hansen, Charlotte T ^a   Münster, Anna Marie ^b   Nielsen, Lars ^b   Pedersen, Per ^b   Abildgaard, Niels ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Biological variation; Critical difference; Multiple myeloma; Reference interval; Serum free light chains

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; ASSAY; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; QUALITY CONTROL; REFERENCE VALUE; SERUM FREE LIGHT CHAIN ASSAY; VALIDATION STUDY;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEPHELOMETRY AND TURBIDIMETRY; PARAPROTEINEMIAS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84869866223     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12013     Document Type: Article

References (18)

1. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673-80.
2. Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2008;23:215-24.
3. Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467-73.
4. Tate JR, Mollee P, Dimeski G, Carter AC, Gill D. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clin Chim Acta 2007;376:30-6.
5. Fraser GG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
6. Fraser CG, Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem 1993;39:1447-53.
7. Ford RP, Mitchell PE, Fraser CG. Desirable performance characteristics and clinical utility of immunoglobulin and light-chain assays derived from data on biological variation. Clin Chem 1988;34:1733-6.
8. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-44.
9. Pattenden RJ, Rogers SY, Wenham PR. Serum free light chains; the need to establish local reference intervals. Ann Clin Biochem 2007;44:512-5.
10. Beetham R, Wassell J, Wallage MJ, Whiteway AJ, James JA. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies? Ann Clin Biochem 2007;44:516-22.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
12. Pollock MA, Jefferson SG, Kane JW, Lomax K, MacKinnon G, Winnard CB. Method comparison-a different approach. Ann Clin Biochem 1992;29:556-60.
13. Jensen E, Petersen PH, Blaabjerg O, Hansen PS, Brix TH, Kyvik KO, Hegedus L. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin Chem Lab Med 2004;42:824-32.
14. Katzmann JA, Snyder MR, Rajkumar SV, Kyle RA, Therneau TM, Benson JT, Dispenzieri A. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem 2011;57:1687-92.
15. Briand P-Y, Decaux O, Caillon H, Grosbois B, Treut AL, Guenet L. Analytical performance of the serum free light chain assay. Clin Chem Lab Med 2009;48:73-9.
16. Smith LJ, Long J, Carr-Smith HD, Bradwell AR. Measurement of immunoglobulin free light chains by automated homogeneous immunoassay in serum and plasma samples. Clin Chem 2003;49:Presentation Number D-58.
17. Smith LJ, Long J, Matters DJ, Carr-Smith HD, Bradwell AR. Sample storage and stability for free light chain assays. Clin Chem 2003;49:Presentation Number D-61.
18. Consensus guidelines for diagnostic criteria and indication for treatment and retreatment in plasma cell disorders. http://www.myeloma-paris2011 com/files/files/ConsensusPanel2The-Final pdf 2011.